Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV001279619 | SCV004807066 | uncertain significance | Wilson disease | 2024-03-26 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001279619 | SCV004844514 | uncertain significance | Wilson disease | 2024-07-29 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with phenylalanine at codon 1432 of the ATP7B protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with Wilson disease (PMID: 26799313). This variant has been identified in 3/249508 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Natera, |
RCV001279619 | SCV001466727 | uncertain significance | Wilson disease | 2020-04-28 | no assertion criteria provided | clinical testing |